Hamish A. L. Lemmey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hamish A. L. Lemmey has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Christopher J. Garland
Department of Pharmacology University of Oxford Oxford UK
3 shared publications - Kim A. Dora
Department of Pharmacology University of Oxford Oxford UK
3 shared publications - Xi Ye
Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK
2 shared publications - Chloe Powell
The Vascular Pharmacology Group, Department of Pharmacology, University of Oxford , Mansfield Road, Oxford, OX1 3QT, UK
1 shared publication - Christopher R. Triggle
Department of Pharmacology, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha 24144, Qatar
1 shared publication - Fiona C. Leiper
MRC Laboratory of Medical Sciences (LMS) London UK
1 shared publication
Latest Publications
- 23 May 2024
- Published by BMJ in BMJ Evidence-Based Medicine
- Vol. 30 (1) , 71-74
Pilot study on large language models for risk-of-bias assessments in systematic reviews: A(I) new type of bias?
- 23 May 2024
- Published by BMJ in BMJ Evidence-Based Medicine
- Vol. 30 (1) , 71-74
Pilot study on large language models for risk-of-bias assessments in systematic reviews: A(I) new type of bias?
- Open Access
- 1 April 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (4) , 764-775
Asymmetric Dimethylarginine Enables Depolarizing Spikes and Vasospasm in Mesenteric and Coronary Resistance Arteries
BACKGROUND: Increased vasoreactivity due to reduced endothelial NO bioavailability is an underlying feature of cardiovascular disease, including hypertension. In small resistance arteries, declining NO enhances vascular smooth muscle (VSM) reactivity partly by enabling rapid depolarizing Ca 2+ -based spikes that underlie vasospasm. The endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) is metabolized by DDAH1 (dimethylarginine dimethylaminohydrolase 1) and elevated in cardiovascular disease. We hypothesized ADMA might enable VSM spikes and vasospasm by reducing NO bioavailability, which is opposed by DDAH1 activity and L-arginine. METHODS: Rat isolated small mesenteric arteries and myogenic rat-isolated intraseptal coronary arteries (RCA) were studied using myography, VSM intracellular recording, Ca 2+ imaging, and DDAH1 immunolabeling. Exogenous ADMA was used to inhibit NO synthase and a selective DDAH1 inhibitor, N G -(2-methoxyethyl) arginine, to assess the functional impact of ADMA metabolism. RESULTS: ADMA enhanced rat-isolated small mesenteric arteries vasoreactivity to the α 1 -adrenoceptor agonist, phenylephrine by enabling T-type voltage-gated calcium channel-dependent depolarizing spikes. However, some endothelium-dependent NO-vasorelaxation remained, which was sensitive to DDAH1-inhibition with N G -(2-methoxyethyl) arginine. In myogenically active RCA, ADMA alone stimulated depolarizing Ca 2+ spikes and marked vasoconstriction, while NO vasorelaxation was abolished. DDAH1 expression was greater in rat-isolated small mesenteric arteries endothelium compared with RCA, but low in VSM of both arteries. L-arginine prevented depolarizing spikes and protected NO-vasorelaxation in rat-isolated small mesenteric artery and RCA. CONCLUSIONS: ADMA increases VSM electrical excitability enhancing vasoreactivity. Endothelial DDAH1 reduces this effect, and low levels of DDAH1 in RCAs may render them susceptible to endothelial dysfunction contributing to vasospasm, changes opposed by L-arginine.
- 1 April 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (4) , 764-775
Open AccessAsymmetric Dimethylarginine Enables Depolarizing Spikes and Vasospasm in Mesenteric and Coronary Resistance Arteries
BACKGROUND: Increased vasoreactivity due to reduced endothelial NO bioavailability is an underlying feature of cardiovascular disease, including hypertension. In small resistance arteries, declining NO enhances vascular smooth muscle (VSM) reactivity partly by enabling rapid depolarizing Ca 2+ -based spikes that underlie vasospasm. The endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) is metabolized by DDAH1 (dimethylarginine dimethylaminohydrolase 1) and elevated in cardiovascular disease. We hypothesized ADMA might enable VSM spikes and vasospasm by reducing NO bioavailability, which is opposed by DDAH1 activity and L-arginine. METHODS: Rat isolated small mesenteric arteries and myogenic rat-isolated intraseptal coronary arteries (RCA) were studied using myography, VSM intracellular recording, Ca 2+ imaging, and DDAH1 immunolabeling. Exogenous ADMA was used to inhibit NO synthase and a selective DDAH1 inhibitor, N G -(2-methoxyethyl) arginine, to assess the functional impact of ADMA metabolism. RESULTS: ADMA enhanced rat-isolated small mesenteric arteries vasoreactivity to the α 1 -adrenoceptor agonist, phenylephrine by enabling T-type voltage-gated calcium channel-dependent depolarizing spikes. However, some endothelium-dependent NO-vasorelaxation remained, which was sensitive to DDAH1-inhibition with N G -(2-methoxyethyl) arginine. In myogenically active RCA, ADMA alone stimulated depolarizing Ca 2+ spikes and marked vasoconstriction, while NO vasorelaxation was abolished. DDAH1 expression was greater in rat-isolated small mesenteric arteries endothelium compared with RCA, but low in VSM of both arteries. L-arginine prevented depolarizing spikes and protected NO-vasorelaxation in rat-isolated small mesenteric artery and RCA. CONCLUSIONS: ADMA increases VSM electrical excitability enhancing vasoreactivity. Endothelial DDAH1 reduces this effect, and low levels of DDAH1 in RCAs may render them susceptible to endothelial dysfunction contributing to vasospasm, changes opposed by L-arginine.
- Open Access
- 1 April 2018
- Published by Elsevier in Vascular Pharmacology
- Vol. 103-105, 29-35
Hyperglycaemia disrupts conducted vasodilation in the resistance vasculature of db/db mice
- 1 April 2018
- Published by Elsevier in Vascular Pharmacology
- Vol. 103-105, 29-35
Open AccessHyperglycaemia disrupts conducted vasodilation in the resistance vasculature of db/db mice
- 4 July 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 10 (486)
Voltage-dependent Ca 2+ entry into smooth muscle during contraction promotes endothelium-mediated feedback vasodilation in arterioles
Ca 2+ entry into vascular smooth muscle activates Ca 2+ signaling in the endothelium to protect tissue blood flow.
- 4 July 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 10 (486)
Voltage-dependent Ca 2+ entry into smooth muscle during contraction promotes endothelium-mediated feedback vasodilation in arterioles
Ca 2+ entry into vascular smooth muscle activates Ca 2+ signaling in the endothelium to protect tissue blood flow.